For Residents

Don’t balk at using medical therapy to manage alcohol use disorder

Author and Disclosure Information

 

References

There are 4 FDA-approved medications for AUD (Table); many others are off-label. It is advisable to start with an FDA-approved medication such as disulfiram for the motivated patient who has a collaborator and desires complete abstinence; naltrexone for a patient who wants to cut down on intake (a long-acting formulation can be used for poorly adherent patients); and acamprosate for a patient with at least some established sobriety who needs help with post-withdrawal sleep disturbances.

FDA-approved pharmacotherapy for alcohol use disorder

With regard to off-label medications, topiramate has the highest evidence for efficacy. Gabapentin can augment naltrexone and also helps with sleep, anxiety, withdrawal, and cravings.4,5

Psychosocial interventions

Medications are just 1 tool in recovery; patients should be engaged in a program of counseling. Encourage attendance at AA meetings. An up-and-coming concept is the use of smartphone applications to prevent relapse (or even induce remission); apps that provide an accurate blood alcohol tracking systems and integrated psychosocial therapies are in the pipeline. The novel Reddit online forum r/StopDrinking is a 24-hour peer-support community that relies on
fellowship, accountability, monitoring, and anonymity; the forum can compete with
motivational interviewing for efficacy in increasing abstinence and preventing relapse.

Pages

Recommended Reading

Psychiatric disorders often impair antiretroviral adherence in perinatally HIV-infected teens
MDedge Psychiatry
Consistent urine screens recommended for patients on opioids
MDedge Psychiatry
Extended-release naltrexone helps alcohol-dependent HIV-positive prisoners transition to community
MDedge Psychiatry
Core curriculum for opioid prescribing preempts certification
MDedge Psychiatry
Elbasvir-grazoprevir works effectively against HCV despite current drug use
MDedge Psychiatry
Primary care’s rising role in behavioral health requires specialty partnerships
MDedge Psychiatry
Extreme alcohol use worsens HIV disease
MDedge Psychiatry
VIDEO: Varenicline underused for smoking cessation
MDedge Psychiatry
FDA: New labeling warns against combining opioids, benzodiazepines
MDedge Psychiatry
10 tips to mitigate legal risks of opioid prescribing
MDedge Psychiatry